p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.
about
A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein responseThe p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complexFBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascadePhosphoinositides: tiny lipids with giant impact on cell regulationOrgan-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinaseThe PI3K regulatory subunits p55α and p50α regulate cell death in vivo.Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy.Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction.Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.Sirt1 inhibits akt2-mediated porcine adipogenesis potentially by direct protein-protein interaction.Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene PIK3R1 haplotype is associated with body fat and serum leptin in a female twin populationSignal transducer and activator of transcription 3 and the phosphatidylinositol 3-kinase regulatory subunits p55α and p50α regulate autophagy in vivo.The two faces of Janus kinases and their respective STATs in mammary gland development and cancerClass IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.p85β regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis.Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice.Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartumPI3-kinase mutation linked to insulin and growth factor resistance in vivoInsulin sensitivity: modulation by nutrients and inflammation.Role of phosphoinositide 3-kinase signaling in autoimmunity.Adipose tissue insulin sensitivity and macrophage recruitment: Does PI3K pick the pathway?Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.Hepatic transcriptome implications for palm fruit juice deterrence of type 2 diabetes mellitus in young male Nile rats.Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice.Phosphatidyl inositol 3-kinase signaling in hypothalamic proopiomelanocortin neurons contributes to the regulation of glucose homeostasis.Phosphoinositide 3-kinase signaling in the vertebrate retina.The PI3K signaling pathway mediates the biological effects of leptin.PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α.Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms.Calorie restriction increases the ratio of phosphatidylinositol 3-kinase catalytic to regulatory subunits in rat skeletal muscle.Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function.PI3K signaling: a crossroads of metabolic regulationThe Human Obesity Gene Map: The 2004 Update
P2860
Q24305069-D936616F-4251-4661-B6BF-7C535582E741Q24310123-02B7BC7E-AE95-4A23-95FD-8A484269F529Q24338848-A5107B7E-EFCF-44B6-A90F-F3AEECD5D610Q27012953-8ACA0164-3BE8-4084-9C8F-43AEFA86F9E2Q33680436-4B01AF15-A618-47E3-BC9A-F470A34F09E5Q33860786-4B0E46D8-6638-4D4B-AF46-824E4ED5D468Q33877581-93AF1770-0C82-41AA-B78A-D8EFB4F490C8Q33895741-7921E2E7-8E5C-4A54-A0D2-DA21A0D96D05Q34035704-5B3BDD7A-4EB8-463B-87F9-0769C1F24DADQ34097448-6F0C1B73-D9FB-47F7-916F-6E8E5BE9B900Q34222778-7EC73010-6EBA-41D3-B231-0008880CF393Q34882666-2C3BC102-C685-470B-9D65-8E819A618E72Q34949971-FA90265D-609A-49A3-94A0-97DD6FA22634Q35112931-9E95DFBE-BCE9-402C-87D2-573D3A8C3991Q35190557-B221CABF-56F2-4D7B-86F3-3F9C91CF6765Q35685851-E8714376-A08E-461F-8724-05E8832A8F67Q35808718-F9F09BF7-678E-4DCC-B129-A797878494F8Q35953378-037CB3D5-D325-4347-AB7F-FE7C6498D22AQ36249797-5F597356-290E-43D6-AC3C-14B98038ECA6Q36419186-EB298FE2-5EA5-403E-803D-4CECB5135444Q36737908-9AED578A-ACF4-44B4-BE34-D13554961E93Q36848937-6317C487-3761-4C53-BCB6-ED8C82AF3BD8Q36922987-8059908E-9411-4BD6-B5F3-D55CC9760D96Q37129090-F822BC78-BF30-448D-A6D4-FF104CFB095DQ37351598-8E591A22-5F11-4D7D-AF64-C67F3CCB8A74Q37358926-7BE8FC4A-6B6B-4A56-98AE-B1819BD3BF62Q37369378-77D0CE18-9B53-4C2D-8955-EAC3765512D5Q37418266-DF5748AE-C3E6-4246-9C85-B56847C04F47Q37463310-CC29C0F2-B2E7-45DA-AA4B-0C44E3B8D2E3Q37810478-6C1EE5D0-A3A3-4E39-BFF7-D66101E61A82Q38718336-FE1175B4-3A36-4975-8DA1-A7295D098C40Q39102072-F4786BF0-C2A7-4787-924D-53B416D20ED9Q45197588-77F977DC-2A39-4B51-9F96-3E1C5A33C614Q46142489-2D949E6D-A6E0-4EE0-8E33-8F7DD2E20DE8Q51500299-F14F6CF9-7CE3-4ADB-88F8-BDAA49AD7679Q57006161-660557AC-39AE-415F-AA08-8DF0CC9E78BCQ57316399-AA228A01-AE4D-4574-922D-41C624208A85
P2860
p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@ast
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@en
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@nl
type
label
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@ast
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@en
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@nl
prefLabel
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@ast
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@en
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@nl
P2093
P2860
P1476
p50alpha/p55alpha phosphoinosi ...... enhanced insulin sensitivity.
@en
P2093
Alison Jozsi
Franck Mauvais-Jarvis
Laurie J Goodyear
Matthias Bluher
Simon J Fisher
P2860
P304
P356
10.1128/MCB.24.1.320-329.2004
P407
P577
2004-01-01T00:00:00Z